Key facts
| Price (PPV) | 34.60 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | furosemide |
| Class | Diuretics |
| ATC code | C03CA01 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boîte de 20 |
| Nature | Médicament |
| Hospital price | 21.60 MAD |
| Data collected on | 9/8/2026 |
Indications
Oedèmes d'origine cardiaque et hépatique (ascite). Oedèmes d'origine rénale (en cas de syndrome néphrotique, le traitement de l'affection de base sera prioritaire). Oedèmes consécutifs à des brûlures. Hypertension de gravité légère à moyenne.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 2 other products contain the same active substance as Lasilix 40 mg (Furosemide), at the same strength and in the same dosage form. For the same pack size (Boîte de 20), the cheapest is Duresan 40 mg (PHARMA5) at 18.30 MAD, i.e. 47 % less than Lasilix 40 mg (34.60 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Duresan 40 mg | PHARMA5 | Boîte de 20 | 18.30 MAD | 0.92 / unit | −47 % |
| Furilan 40 mg | LAPROPHAN | Boîte de 20 | 20 MAD | 1 / unit | −42 % |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Lasilix 40 mg
Lasilix 40 mg belongs to the diuretics therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Lasilix 40 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Lasilix 40 mg
Answers to common questions from Moroccan patients about this drug.